Wegovy’s hidden benefit to treat a disease suffered by 1 in 3 adults | Society

Medications to combat obesity such as Ozempic or Wegovy are booming in recent years. Although they were initially conceived to treat type 2 diabetes, the use of the drug for this Health problem has become secondary and is used more in weight loss diets.

The Spanish Agency for Medicines and Health Products (AEMPS) came to alert the supply crisis to the growing demand and experts continue to warn about their possible side effects, recommending their responsible use under medical supervision.

The head of the Endocrinology and Nutrition Service of the Quiron University Hospital in Madrid, Esteban Jódar, has warned of the possible side effects of this type of medicines, which pass from simple nausea to diarrhea, extreme or vomiting. In addition, for obese people who lose very fast weight with the drug there is also the risk of appearance of gallbladder diseases or alterations in the optical nerve.

However, Jódar believes that if you have to put on a balance what this medicine has demonstrated in weight reduction, reduction of cardiovascular events in diabetic or obese people and in renal or cardiac failure, the medicine is “really impressive and beneficial.”

Also beneficial to treat fatty liver

In addition to these benefits, a recent study demonstrates that the Wegovy medication also serves to treat a disease that affects one in three adults, that of the fatty liver, which in its most serious forms can trigger in cirrhosis or liver cancer.

“In this study, what must be highlighted is that it is a prescribed analysis, almost 1,200 patients are proven by biopsy the existence of this disease and when the first 800 have arrived at week 72, the biopsy has been repeated and those are the data that has just been communicated to communicate,” said Jódar, which points out that the study shows “a very important reduction in liver fibrosis without worsening the stoat.”